In the week of April 20, 2026, 19 holders filed a new Schedule 13D and 91 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Lincoln National Corporation's 80.94% of Lincoln Partners Group Royalty Fund (Schedule 13D, April 20, 2026).
New 13D19
New 13G91
Stated intents0
The week of 2026-04-20, 19 holders filed a new Schedule 13D and 91 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-20 | Lincoln Partners Group Royalty Fund | Lincoln National Corporation | 80.94% | SCHEDULE 13D |
| 2026-04-20 | Lincoln Bain Capital Total Credit Fund | Lincoln National Corporation | 62.57% | SCHEDULE 13D |
| 2026-04-24 | Jyong Biotech Ltd. | Perfect Minds Co., Ltd | 33.34% | SCHEDULE 13D |
| 2026-04-23 | Kailera Therapeutics, Inc. | BCPE Perseus Investor, LP | 20.27% | SCHEDULE 13D |
| 2026-04-20 | Reliability Inc | Jeffrey E. Eberwein | 19% | SCHEDULE 13D |
| 2026-04-23 | Kailera Therapeutics, Inc. | BCLS Fund IV Investments, L.P. | 17.43% | SCHEDULE 13D |
| 2026-04-24 | SMX (Security Matters) PLC | Haggai Alon | 16.24% | SCHEDULE 13D |
| 2026-04-24 | Achieve Life Sciences, Inc. | Tpg Gp A, LLC | 12.6% | SCHEDULE 13D |
| 2026-04-22 | Pulmatrix, Inc. | RCM Eos PIPE HOLDINGS, LLC | 9.99% | SCHEDULE 13D |
| 2026-04-23 | Alamar Biosciences, Inc. | Illumina Innovation Fund II, L.P. | 9.6% | SCHEDULE 13D |
| 2026-04-21 | ImageneBio, Inc. | Omega Fund VI, L.P. | 8.4% | SCHEDULE 13D |
| 2026-04-20 | Antalpha Platform Holding Co | Tether Global Investments Fund, S.I.C.A.F., S.A. | 8.2% | SCHEDULE 13D |
| 2026-04-20 | Ionetix Corp / DE / | Shamrock Ionetix LLC | 7.2% | SCHEDULE 13D |
| 2026-04-22 | Reliability Inc | Mark R. Speck | 7.01% | SCHEDULE 13D |
| 2026-04-23 | Alamar Biosciences, Inc. | Sands Capital Life Sciences Pulse Fund II, L.P. | 6.3% | SCHEDULE 13D |
| 2026-04-20 | Silicom Ltd. | Eizenman Avinoam | 5.7% | SCHEDULE 13D |
| 2026-04-24 | InspireMD, Inc. | Marvin Slosman | 5.18% | SCHEDULE 13D |
| 2026-04-24 | Mannatech Inc | Toth Robert | 5.1% | SCHEDULE 13D |
| 2026-04-22 | Truworths International Ltd | Standard Bank Of South Africa Ltd | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-22 | BTQ Technologies Corp. | Olivier Roussy Newton | 30.4% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Brendan Klare | 25.3% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Joshua Klontz | 25.3% | SCHEDULE 13G |
| 2026-04-24 | Guardian Metal Resources PLC | UCAM Limited | 24.4% | SCHEDULE 13G |
| 2026-04-20 | Ionetix Corp / DE / | Ospraie Real Assets Fund LP | 19.9% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Scott Klum | 16.8% | SCHEDULE 13G |
| 2026-04-23 | Cyabra, Inc. | Trailblazer Sponsor Group, LLC | 15.6% | SCHEDULE 13G |
| 2026-04-23 | LEE ENTERPRISES, Inc | Quint Digital Ltd | 14.6% | SCHEDULE 13G |
| 2026-04-23 | AGI Inc | Lumina Capital Management Ltda. | 13.7% | SCHEDULE 13G |
| 2026-04-20 | Lucid Group, Inc. | Uber Technologies, Inc | 11.52% | SCHEDULE 13G |
| 2026-04-22 | Abits Group Inc | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-04-22 | Cyngn Inc. | Empery Asset Management, LP | 9.99% | SCHEDULE 13G |
| 2026-04-22 | Momentus Inc. | Kenneth Griffin | 9.99% | SCHEDULE 13G |
| 2026-04-24 | Curis, Inc. | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G |
| 2026-04-20 | TransCode Therapeutics, Inc. | YA II PN, Ltd. | 9.9% | SCHEDULE 13G |
| 2026-04-21 | ImageneBio, Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2026-04-23 | zSpace, Inc. | 3i, LP | 9.9% | SCHEDULE 13G |
| 2026-04-23 | Capstone Holding Corp. | 3i, LP | 9.9% | SCHEDULE 13G |
| 2026-04-20 | Hartford Funds Exchange-Traded Trust | Truist Financial Corp | 9.3% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Paradigm BioCapital Advisors LP | 9.2% | SCHEDULE 13G |
| 2026-04-22 | First Tracks Biotherapeutics Inc | EcoR1 Capital, LLC | 9.1% | SCHEDULE 13G |
| 2026-04-22 | Franklin Covey Co | Royce & Associates LP | 9.03% | SCHEDULE 13G |
| 2026-04-24 | MKDWELL Tech Inc. | Lu Huang | 8.8% | SCHEDULE 13G |
| 2026-04-20 | ETF Opportunities Trust | Truist Financial Corp | 8.6% | SCHEDULE 13G |
| 2026-04-23 | 1606 Corp. | Greg Paul Lambrecht | 8.6% | SCHEDULE 13G |
| 2026-04-22 | OSR Health, Inc. | joint protein central inc. | 7.9% | SCHEDULE 13G |
| 2026-04-24 | Soundthinking, Inc. | Kopion Asset Management, LLC | 7.9% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | Benjamin Klein | 7.8% | SCHEDULE 13G |
| 2026-04-23 | Applied Energetics, Inc. | Ingalls & Snyder LLC | 7.7% | SCHEDULE 13G |
| 2026-04-24 | Liveone Inc | Broadcast Music, LLC | 7.6% | SCHEDULE 13G |
| 2026-04-21 | NeuroOne Medical Technologies Corporation | Brian Pratt | 7.4% | SCHEDULE 13G |
| 2026-04-22 | Pasithea Therapeutics Corp. | Funicular Funds, LP | 7.4% | SCHEDULE 13G |
| 2026-04-21 | Nicola Mining Inc. | Kenneth Griffin | 7.2% | SCHEDULE 13G |
| 2026-04-21 | Hurco Companies, Inc. | Carl K. Oppenheimer | 7.14% | SCHEDULE 13G |
| 2026-04-23 | Avnet Inc | Pzena Investment Management LLC | 7.1% | SCHEDULE 13G |
| 2026-04-22 | Micropolis AI Robotics | Fares Mohd Said Mustafa Abubaker | 6.75% | SCHEDULE 13G |
| 2026-04-21 | Lyell Immunopharma, Inc. | Euler Fund, L.P. | 6.71% | SCHEDULE 13G |
| 2026-04-20 | First Trust Exchange-Traded Fund VI | Truist Financial Corp | 6.7% | SCHEDULE 13G |
| 2026-04-20 | Rank One Computing Corp | B. Scott Swann | 6.7% | SCHEDULE 13G |
| 2026-04-22 | Transcat Inc | Royce & Associates LP | 6.58% | SCHEDULE 13G |
| 2026-04-22 | BRC Group Holdings Inc | Daniel Asher | 6.54% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Frazier Life Sciences Public Fund, L.P. | 6.5% | SCHEDULE 13G |
| 2026-04-24 | JATT II Acquisition Corp. | Great Point Partners, LLC | 6.41% | SCHEDULE 13G |
| 2026-04-21 | The Vita Coco Company, Inc. | Wasatch Advisors LP | 6.4% | SCHEDULE 13G |
| 2026-04-24 | JATT II Acquisition Corp. | Commodore Capital LP | 6.4% | SCHEDULE 13G |
| 2026-04-20 | Spacsphere Acquisition Corp. | Wolverine Asset Management, LLC | 6.39% | SCHEDULE 13G |
| 2026-04-20 | Zacks Trust | Truist Financial Corp | 6.2% | SCHEDULE 13G |
| 2026-04-22 | CI&T Inc | Royce & Associates LP | 6.2% | SCHEDULE 13G |
| 2026-04-22 | Enhanced Group Inc. | Harraden Circle Investments, LLC | 6.17% | SCHEDULE 13G |
| 2026-04-20 | Golar Lng Ltd | TOMS Capital Investment Management LP | 6.1% | SCHEDULE 13G |
| 2026-04-22 | Esperion Therapeutics, Inc. | Wasatch Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-04-22 | American Integrity Insurance Group, Inc. | Wasatch Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-04-21 | Diana Shipping Inc. | F. Laeisz GmbH | 6% | SCHEDULE 13G |
| 2026-04-20 | Newbridge Acquisition Ltd | Wolverine Asset Management, LLC | 5.97% | SCHEDULE 13G |
| 2026-04-21 | Everus Construction Group Inc | Wasatch Advisors LP | 5.9% | SCHEDULE 13G |
| 2026-04-20 | Staar Surgical Co | Madison Avenue International LP | 5.8% | SCHEDULE 13G |
| 2026-04-24 | QuasarEdge Acquisition Corp | Harraden Circle Investments, LLC | 5.78% | SCHEDULE 13G |
| 2026-04-22 | Diamond Hill Investment Group | Glazer Capital, LLC | 5.75% | SCHEDULE 13G |
| 2026-04-22 | Optex Systems Holdings Inc | Wasatch Advisors LP | 5.7% | SCHEDULE 13G |
| 2026-04-20 | Andretti Acquisition Corp. II | Wolverine Asset Management, LLC | 5.66% | SCHEDULE 13G |
| 2026-04-22 | HiTek Global Inc. | China Legends management Consultancy Limited | 5.64% | SCHEDULE 13G |
| 2026-04-20 | Blueport Acquisition Ltd | Wolverine Asset Management, LLC | 5.61% | SCHEDULE 13G |
| 2026-04-21 | Barrett Business Services, Inc. | Royce & Associates LP | 5.45% | SCHEDULE 13G |
| 2026-04-22 | Hingham Institution for Savings | Royce & Associates LP | 5.42% | SCHEDULE 13G |
| 2026-04-21 | Sutro Biopharma, Inc. | Perceptive Advisors LLC | 5.4% | SCHEDULE 13G |
| 2026-04-23 | UFP Technologies Inc | Congress Asset Management Co | 5.4% | SCHEDULE 13G |
| 2026-04-23 | Surrozen, Inc. | Point72 Asset Management, L.P. | 5.4% | SCHEDULE 13G |
| 2026-04-24 | Dave Inc. | Jane Street Group, LLC | 5.4% | SCHEDULE 13G |
| 2026-04-22 | Radiant Logistics, Inc. | Royce & Associates LP | 5.39% | SCHEDULE 13G |
| 2026-04-23 | CSW Industrials Inc | Wasatch Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-23 | Palatin Technologies Inc | AuGC BioFund LP | 5.3% | SCHEDULE 13G |
| 2026-04-24 | Safeguard Acquisition Corp. | Linden Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-21 | SEACOR Marine Holdings Inc. | Carl K. Oppenheimer | 5.24% | SCHEDULE 13G |
| 2026-04-20 | Datacentrex, Inc. | Eleven Ventures LLC | 5.2% | SCHEDULE 13G |
| 2026-04-22 | Maywood Acquisition Corp. 2 | Whitebox Advisors LLC | 5.2% | SCHEDULE 13G |
| 2026-04-22 | Lennox International Inc | Viking Global Investors LP | 5.2% | SCHEDULE 13G |
| 2026-04-23 | Madison Air Solutions Corp | Durable Capital Partners LP | 5.2% | SCHEDULE 13G |
| 2026-04-24 | Achieve Life Sciences, Inc. | Venrock Healthcare Capital Partners III, L.P. | 5.2% | SCHEDULE 13G |
| 2026-04-20 | Solarius Capital Acquisition Corporation | Wolverine Asset Management, LLC | 5.18% | SCHEDULE 13G |
| 2026-04-20 | Miluna Acquisition Corp | Wolverine Asset Management, LLC | 5.15% | SCHEDULE 13G |
| 2026-04-20 | First Trust Exchange-Traded Fund | Truist Financial Corp | 5.1% | SCHEDULE 13G |
| 2026-04-20 | SkinHealth Systems Inc. | Integrated Core Strategies (US) LLC | 5.1% | SCHEDULE 13G |
| 2026-04-20 | GalaxyEdge Acquisition Corp | Wolverine Asset Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-04-22 | Moelis & Co | Wasatch Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-23 | PagerDuty Inc | The Goldman Sachs Group, Inc. | 5.1% | SCHEDULE 13G |
| 2026-04-24 | Happen Inc | Bay Pond Partners, L.P. | 5.1% | SCHEDULE 13G |
| 2026-04-24 | Happen Inc | Bay Pond Investors (Bermuda) L.P. | 5.1% | SCHEDULE 13G |
| 2026-04-20 | Lion Copper Corp. | Truist Financial Corp | 5% | SCHEDULE 13G |
| 2026-04-20 | Morgan Stanley India Investment Fund, Inc. | Gates Foundation Trust | 5% | SCHEDULE 13G |
| 2026-04-22 | Spyre Therapeutics, Inc. | Perceptive Advisors LLC | 5% | SCHEDULE 13G |
| 2026-04-23 | Spirit Aviation Holdings, Inc | Galkin Vladimir | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)110 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.